Literature DB >> 12057902

An invasion-independent pathway of blood-borne metastasis: a new murine mammary tumor model.

Takashi Sugino1, Takashi Kusakabe, Nobuo Hoshi, Tomiko Yamaguchi, Takanori Kawaguchi, Steve Goodison, Masayuki Sekimata, Yoshimi Homma, Toshimitsu Suzuki.   

Abstract

It is generally believed that active invasion by cancer cells is essential to the metastatic process. In this report, we describe a murine mammary tumor (MCH66) model of metastasis that does not require invasion into the vascular wall of both the primary tumor and the target organ, in this case, the lung. The process involves intravasation of tumor nests surrounded by sinusoidal blood vessels, followed by intravascular tumor growth in the lung, without penetration of the vascular wall during the process. Comparative studies using a nonmetastatic MCH66 clone (MCH66C8) and another highly invasive metastatic cell line (MCH416) suggested that high angiogenic activity and sinusoidal remodeling of tumor blood vessels were prerequisites for MCH66 metastasis. Differential cDNA analysis identified several genes that were overexpressed by MCH66, including genes for the angiogenesis factor pleiotrophin, and extracellular matrix-associated molecules that may modulate the microenvironment toward neovascularization. Our analyses suggest that tumor angiogenesis plays a role in the induction of invasion-independent metastasis. This model should prove useful in screening and development of new therapeutic agents for cancer metastasis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12057902      PMCID: PMC1850839          DOI: 10.1016/S0002-9440(10)61147-9

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  17 in total

1.  Matrilin-2, a large, oligomeric matrix protein, is expressed by a great variety of cells and forms fibrillar networks.

Authors:  D Piecha; S Muratoglu; M Mörgelin; N Hauser; D Studer; I Kiss; M Paulsson; F Deák
Journal:  J Biol Chem       Date:  1999-05-07       Impact factor: 5.157

2.  A heparin-binding angiogenic protein--basic fibroblast growth factor--is stored within basement membrane.

Authors:  J Folkman; M Klagsbrun; J Sasse; M Wadzinski; D Ingber; I Vlodavsky
Journal:  Am J Pathol       Date:  1988-02       Impact factor: 4.307

3.  The relationship of embolic homogeneity, number, size and viability to the incidence of experimental metastasis.

Authors:  I J Fidler
Journal:  Eur J Cancer       Date:  1973-03       Impact factor: 9.162

4.  The significance of hematogenous tumor cell clumps in the metastatic process.

Authors:  L A Liotta; M G Saidel; J Kleinerman
Journal:  Cancer Res       Date:  1976-03       Impact factor: 12.701

5.  DANCE, a novel secreted RGD protein expressed in developing, atherosclerotic, and balloon-injured arteries.

Authors:  T Nakamura; P Ruiz-Lozano; V Lindner; D Yabe; M Taniwaki; Y Furukawa; K Kobuke; K Tashiro; Z Lu; N L Andon; R Schaub; A Matsumori; S Sasayama; K R Chien; T Honjo
Journal:  J Biol Chem       Date:  1999-08-06       Impact factor: 5.157

6.  Primary structure and expression of matrilin-2, the closest relative of cartilage matrix protein within the von Willebrand factor type A-like module superfamily.

Authors:  F Deák; D Piecha; C Bachrati; M Paulsson; I Kiss
Journal:  J Biol Chem       Date:  1997-04-04       Impact factor: 5.157

7.  Reduced angiogenesis and tumor progression in gelatinase A-deficient mice.

Authors:  T Itoh; M Tanioka; H Yoshida; T Yoshioka; H Nishimoto; S Itohara
Journal:  Cancer Res       Date:  1998-03-01       Impact factor: 12.701

8.  Comparative sequence of human and mouse BAC clones from the mnd2 region of chromosome 2p13.

Authors:  W Jang; A Hua; S V Spilson; W Miller; B A Roe; M H Meisler
Journal:  Genome Res       Date:  1999-01       Impact factor: 9.043

9.  Ribozyme-targeting elucidates a direct role of pleiotrophin in tumor growth.

Authors:  F Czubayko; A T Riegel; A Wellstein
Journal:  J Biol Chem       Date:  1994-08-19       Impact factor: 5.157

10.  Correlation between circulating cancer cells and incidence of metastases.

Authors:  D Glaves
Journal:  Br J Cancer       Date:  1983-11       Impact factor: 7.640

View more
  30 in total

Review 1.  New paradigm for vessel intravasation by tumor cells.

Authors:  Noel Weidner
Journal:  Am J Pathol       Date:  2002-06       Impact factor: 4.307

2.  Identification of S100A14 as a metastasis-promoting molecule in a murine organotropic metastasis model.

Authors:  Takashi Sugino; Naoki Ichikawa-Tomikawa; Mizuko Tanaka; Namiko Shishito; Tomiko Miura; Masato Abe; Koji Muramatsu; Takuma Oishi; Yuko Kakuda; Takuya Kawata; Yasuto Akiyama
Journal:  Clin Exp Metastasis       Date:  2019-07-01       Impact factor: 5.150

3.  Establishment and characterization of three novel human gastric cancer cell lines with differentiated intestinal phenotype derived from liver metastasis.

Authors:  Hayao Nakanishi; Kenzo Yasui; Yuzuru Ikehara; Hiroyuki Yokoyama; Seiichi Munesue; Yasuhiro Kodera; Masae Tatematsu
Journal:  Clin Exp Metastasis       Date:  2005       Impact factor: 5.150

Review 4.  Molecular analysis of circulating tumour cells-biology and biomarkers.

Authors:  Matthew G Krebs; Robert L Metcalf; Louise Carter; Ged Brady; Fiona H Blackhall; Caroline Dive
Journal:  Nat Rev Clin Oncol       Date:  2014-01-21       Impact factor: 66.675

Review 5.  Targeting tumor cell motility to prevent metastasis.

Authors:  Trenis D Palmer; William J Ashby; John D Lewis; Andries Zijlstra
Journal:  Adv Drug Deliv Rev       Date:  2011-06-02       Impact factor: 15.470

Review 6.  Brain metastases: epidemiology and pathophysiology.

Authors:  Igor T Gavrilovic; Jerome B Posner
Journal:  J Neurooncol       Date:  2005-10       Impact factor: 4.130

Review 7.  Challenges and unanswered questions for the next decade of circulating tumour cell research in lung cancer.

Authors:  Sumitra Mohan; Francesca Chemi; Ged Brady
Journal:  Transl Lung Cancer Res       Date:  2017-08

Review 8.  The pathology of EMT in mouse mammary tumorigenesis.

Authors:  Robert Darrell Cardiff
Journal:  J Mammary Gland Biol Neoplasia       Date:  2010-06-04       Impact factor: 2.673

9.  The secretory leukocyte protease inhibitor (SLPI) suppresses cancer cell invasion but promotes blood-borne metastasis via an invasion-independent pathway.

Authors:  T Sugino; T Yamaguchi; G Ogura; T Kusakabe; S Goodison; Y Homma; T Suzuki
Journal:  J Pathol       Date:  2007-06       Impact factor: 7.996

10.  Neoadjuvant sorafenib treatment of clear cell renal cell carcinoma and release of circulating tumor fragments.

Authors:  Gursah Kats-Ugurlu; Egbert Oosterwijk; Stijn Muselaers; Jeannette Oosterwijk-Wakka; Christina Hulsbergen-van de Kaa; Mirjam de Weijert; Han van Krieken; Ingrid Desar; Carla van Herpen; Cathy Maass; Rob de Waal; Peter Mulders; William Leenders
Journal:  Neoplasia       Date:  2014-04-13       Impact factor: 5.715

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.